Prasad G Iyer

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. pmc Physical activity is associated with reduced risk of esophageal cancer, particularly esophageal adenocarcinoma: a systematic review and meta-analysis
    Siddharth Singh
    Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester 55905MN, USA
    BMC Gastroenterol 14:101. 2014
  2. doi request reprint Physical activity is associated with reduced risk of gastric cancer: a systematic review and meta-analysis
    Siddharth Singh
    Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905
    Cancer Prev Res (Phila) 7:12-22. 2014
  3. pmc Association of Barrett's esophagus with type II Diabetes Mellitus: results from a large population-based case-control study
    Prasad G Iyer
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA
    Clin Gastroenterol Hepatol 11:1108-1114.e5. 2013
  4. pmc Assessment of the diagnostic performance and interobserver variability of endocytoscopy in Barrett's esophagus: a pilot ex-vivo study
    Yutaka Tomizawa
    Yutaka Tomizawa, Prasad G Iyer, Louis M Wongkeesong, Navtej S Buttar, Lori S Lutzke, Kenneth K Wang, Barrett s Esophagus Unit, Division of Gastroenterology and Hepatology, Mayo Clinic Rochester, MN 55905, United States
    World J Gastroenterol 19:8652-8. 2013
  5. pmc Clinical and histologic determinants of mortality for patients with Barrett's esophagus-related T1 esophageal adenocarcinoma
    Cadman L Leggett
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota
    Clin Gastroenterol Hepatol 13:658-64.e1-3. 2015
  6. pmc Safety of endoscopic mucosal resection for Barrett's esophagus
    Yutaka Tomizawa
    Barret s Esophagus Unit, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA
    Am J Gastroenterol 108:1440-7; quiz 1448. 2013
  7. doi request reprint Endoscopic Mucosal Impedance Measurements Correlate With Eosinophilia and Dilation of Intercellular Spaces in Patients With Eosinophilic Esophagitis
    David A Katzka
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota Electronic address
    Clin Gastroenterol Hepatol 13:1242-1248.e1. 2015
  8. pmc Magnitude of Missed Esophageal Adenocarcinoma After Barrett's Esophagus Diagnosis: A Systematic Review and Meta-analysis
    Kavel Visrodia
    Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota
    Gastroenterology 150:599-607.e7. 2016
  9. doi request reprint Detection of peritoneal carcinomatosis by EUS fine-needle aspiration: impact on staging and resectability (with videos)
    Michael J Levy
    Division of Gastroenterology and Hepatology, College of Medicine, Mayo Clinic, Rochester, Minnesota, USA
    Gastrointest Endosc 81:1215-24. 2015
  10. pmc Prediction of response to endoscopic therapy of Barrett's dysplasia by using genetic biomarkers
    Margriet R Timmer
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The Netherlands
    Gastrointest Endosc 80:984-91. 2014

Collaborators

Detail Information

Publications24

  1. pmc Physical activity is associated with reduced risk of esophageal cancer, particularly esophageal adenocarcinoma: a systematic review and meta-analysis
    Siddharth Singh
    Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester 55905MN, USA
    BMC Gastroenterol 14:101. 2014
    ..We performed a systematic review and meta-analysis to evaluate the association between physical activity and risk of esophageal cancer (esophageal adenocarcinoma [EAC] and/or esophageal squamous cell carcinoma [ESCC])...
  2. doi request reprint Physical activity is associated with reduced risk of gastric cancer: a systematic review and meta-analysis
    Siddharth Singh
    Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905
    Cancer Prev Res (Phila) 7:12-22. 2014
    ..Lifestyle interventions focusing on increasing physical activity may decrease the global burden of gastric cancer, in addition to a myriad of other health benefits...
  3. pmc Association of Barrett's esophagus with type II Diabetes Mellitus: results from a large population-based case-control study
    Prasad G Iyer
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA
    Clin Gastroenterol Hepatol 11:1108-1114.e5. 2013
    ..We performed an epidemiologic study to determine whether prior type 2 diabetes mellitus (DM2) is associated with BE...
  4. pmc Assessment of the diagnostic performance and interobserver variability of endocytoscopy in Barrett's esophagus: a pilot ex-vivo study
    Yutaka Tomizawa
    Yutaka Tomizawa, Prasad G Iyer, Louis M Wongkeesong, Navtej S Buttar, Lori S Lutzke, Kenneth K Wang, Barrett s Esophagus Unit, Division of Gastroenterology and Hepatology, Mayo Clinic Rochester, MN 55905, United States
    World J Gastroenterol 19:8652-8. 2013
    ..To investigate a classification of endocytoscopy (ECS) images in Barrett's esophagus (BE) and evaluate its diagnostic performance and interobserver variability...
  5. pmc Clinical and histologic determinants of mortality for patients with Barrett's esophagus-related T1 esophageal adenocarcinoma
    Cadman L Leggett
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota
    Clin Gastroenterol Hepatol 13:658-64.e1-3. 2015
    ..We assessed clinical and histologic variables associated with the overall survival times of patients with T1 EAC who received therapy...
  6. pmc Safety of endoscopic mucosal resection for Barrett's esophagus
    Yutaka Tomizawa
    Barret s Esophagus Unit, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA
    Am J Gastroenterol 108:1440-7; quiz 1448. 2013
    ..Our aim was to determine the complication rates in a large cohort of patients who underwent EMR at a specialized BE unit...
  7. doi request reprint Endoscopic Mucosal Impedance Measurements Correlate With Eosinophilia and Dilation of Intercellular Spaces in Patients With Eosinophilic Esophagitis
    David A Katzka
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota Electronic address
    Clin Gastroenterol Hepatol 13:1242-1248.e1. 2015
    ..We investigated the correlation between site-specific mucosal impedance (MI) measurements of ion flux and esophageal histology, and whether MI measurements can be used to distinguish between patients with active and inactive EoE...
  8. pmc Magnitude of Missed Esophageal Adenocarcinoma After Barrett's Esophagus Diagnosis: A Systematic Review and Meta-analysis
    Kavel Visrodia
    Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota
    Gastroenterology 150:599-607.e7. 2016
    ..These cases of missed cancers have not been well studied, despite current surveillance strategies for BE. We performed a systematic review and meta-analysis to determine the magnitude of missed EAC in cohorts of patients with BE...
  9. doi request reprint Detection of peritoneal carcinomatosis by EUS fine-needle aspiration: impact on staging and resectability (with videos)
    Michael J Levy
    Division of Gastroenterology and Hepatology, College of Medicine, Mayo Clinic, Rochester, Minnesota, USA
    Gastrointest Endosc 81:1215-24. 2015
    ..Peritoneal carcinomatosis (PC) greatly affects cancer staging and resectability...
  10. pmc Prediction of response to endoscopic therapy of Barrett's dysplasia by using genetic biomarkers
    Margriet R Timmer
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The Netherlands
    Gastrointest Endosc 80:984-91. 2014
    ..Endoscopic therapy for the treatment of high-grade dysplasia (HGD) and intramucosal cancer (IMC) in Barrett's esophagus (BE) may not always result in complete remission of dysplasia (CRD)...
  11. pmc Obstructive sleep apnea is a risk factor for Barrett's esophagus
    Cadman L Leggett
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota
    Clin Gastroenterol Hepatol 12:583-8.e1. 2014
    ..The aims of this study were to assess the association between OSA and BE and to determine whether the association is independent of GERD and body mass index (BMI)...
  12. doi request reprint Utility of baseline positron emission tomography with computed tomography for predicting endoscopic resectability and survival outcomes in patients with early esophageal adenocarcinoma
    Gang Sun
    Barrett s Esophagus Unit, Division of Gastroenterology and Hepatology, Mayo Clinic, USA
    J Gastroenterol Hepatol 28:975-81. 2013
    ..We conducted a retrospective study to determine the association of PET/CT findings with histopathological tumor invasion depth and survival outcomes...
  13. pmc Statins are associated with reduced risk of esophageal cancer, particularly in patients with Barrett's esophagus: a systematic review and meta-analysis
    Siddharth Singh
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA
    Clin Gastroenterol Hepatol 11:620-9. 2013
    ..Statins might prevent this cancer. We performed a systematic review with a meta-analysis of studies that evaluated the effect of statins on the risk of esophageal cancer...
  14. pmc Yield of Repeat Endoscopy in Barrett's Esophagus with No Dysplasia and Low-Grade Dysplasia: A Population-Based Study
    Kavel Visrodia
    Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA
    Dig Dis Sci 61:158-67. 2016
    ..The yield of early repeat endoscopy in patients with Barrett's esophagus (BE) is not well established...
  15. doi request reprint Prospective evaluation of adverse events following lower gastrointestinal tract EUS FNA
    Michael J Levy
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA
    Am J Gastroenterol 109:676-85. 2014
    ..Our aim was to determine the incidence and factors associated with AEs following LGI EUS fine needle aspiration (FNA)...
  16. pmc Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysis
    Siddharth Singh
    Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA
    Gut 63:1229-37. 2014
    ....
  17. pmc Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrett's esophagus: results from a US Multicenter Consortium
    Milli Gupta
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA
    Gastroenterology 145:79-86.e1. 2013
    ..We aimed to estimate the incidence and identify factors that predicted the recurrence of IM after successful RFA...
  18. pmc Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis
    Siddharth Singh
    Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota
    Clin Gastroenterol Hepatol 11:1399-1412.e7. 2013
    ....
  19. doi request reprint Effects of topical steroids on tight junction proteins and spongiosis in esophageal epithelia of patients with eosinophilic esophagitis
    David A Katzka
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota Electronic address
    Clin Gastroenterol Hepatol 12:1824-9.e1. 2014
    ..We assessed whether levels of tight junction proteins correlate with the dilation of intercellular spaces (spongiosis) and the effects of topical steroids on these parameters...
  20. pmc Metabolic syndrome as a risk factor for Barrett esophagus: a population-based case-control study
    Cadman L Leggett
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA
    Mayo Clin Proc 88:157-65. 2013
    ..To assess the association between Barrett esophagus (BE) and the metabolic syndrome in patients with and without reflux symptoms and to determine whether this association is reflux independent and metabolically driven...
  21. doi request reprint ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus
    Nicholas J Shaheen
    Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
    Am J Gastroenterol 111:30-50. 2016
    ..Although many of the recommendations provided are based on weak evidence or expert opinion, this document provides a pragmatic framework for the care of the patient with BE. ..
  22. doi request reprint EUS-derived criteria for distinguishing benign from malignant metastatic solid hepatic masses
    Larissa L Fujii-Lau
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA
    Gastrointest Endosc 81:1188-96.e1-7. 2015
    ..Detection of hepatic metastases during EUS is an important component of tumor staging...
  23. doi request reprint Incidence of esophageal adenocarcinoma in Barrett's esophagus with low-grade dysplasia: a systematic review and meta-analysis
    Siddharth Singh
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Gastrointest Endosc 79:897-909.e4; quiz 983.e1, 983.e3. 2014
    ..The natural history of low-grade dysplasia (LGD) in patients with Barrett's esophagus (BE) is unclear...
  24. pmc Diagnosis and management of Barrett's esophagus
    Eric M Nelsen
    Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Surg Clin North Am 92:1135-54. 2012
    ..Careful endoscopic evaluation with high-resolution endoscopy and endoscopic resection is recommended in the evaluation of subjects with high-grade dysplasia and early adenocarcinoma...